Devyser and Thermo Fisher Scientific have entered into a collaboration agreement to promote laboratory services. The goal is to partner with pharmaceutical companies to support their development projects utilizing Devyser’s unique assays in its CLIA-certified laboratory. The companies will work together to promote the Devyser laboratory services to support and advance research and development for pharmaceutical companies.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on TMO:
- Constellation Brands upgraded, Block downgraded: Wall Street’s top analyst calls
- Thermo Fisher resumed with a Buy at Citi
- Vanguard Mega Cap Growth ETF (MGK): Go Big, or Go Home
- Abcam’s (NASDAQ: ABCM) Stock Dips after Danaher Corp’s $5.7 Billion Acquisition Bid
- Microsoft Stock’s (NASDAQ:MSFT) Long-Term Investment Case: Multiple Growth Catalysts